Literature DB >> 12965246

Failure of estrogen to protect the substantia nigra pars compacta of female rats from lesion induced by 6-hydroxydopamine.

Anete Curte Ferraz1, Léder Leal Xavier, Sílvia Hernandes, Martha Sulzbach, Giordano Gubert Viola, Janete A Anselmo-Franci, Matilde Achaval, Claudio Da Cunha.   

Abstract

The immunostaining for tyrosine hydroxylase (TH) in the substantia nigra pars compacta (SNpc) and in the ventral tegmental area (VTA) after intranigral infusion of 6-hydroxydopamine (6-OHDA, 6 microg/side) was analyzed in ovariectomized adult female Wistar rats. Estrogen replacement for 52 days (400-microg 17-beta-estradiol capsules) did not prevent the loss of TH-immunoreactive cells induced by 6-OHDA in the SNpc. This result indicates that the neuroprotective effect of dopaminergic mesencephalic cells is not observed with long-term estrogen replacement.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12965246     DOI: 10.1016/s0006-8993(03)03198-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

Review 1.  Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines.

Authors:  Glenda E Gillies; Simon McArthur
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

2.  Oestrogen receptors enhance dopamine neurone survival in rat midbrain.

Authors:  M L Johnson; C C Ho; A E Day; Q D Walker; R Francis; C M Kuhn
Journal:  J Neuroendocrinol       Date:  2010-01-27       Impact factor: 3.627

3.  Evaluation of estrogen neuroprotective effect on nigrostriatal dopaminergic neurons following 6-hydroxydopamine injection into the substantia nigra pars compacta or the medial forebrain bundle.

Authors:  Anete Curte Ferraz; Francesca Matheussi; Raphael Escorsim Szawka; Vanessa Rizelio; Ana Márcia Delattre; Paula Rigon; Erica do Espírito Santo Hermel; Léder Leal Xavier; Matilde Achaval; Janete A Anselmo-Franci
Journal:  Neurochem Res       Date:  2008-02-09       Impact factor: 3.996

4.  Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease.

Authors:  Simon McArthur; Glenda E Gillies
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-30       Impact factor: 5.555

Review 5.  Sex differences in Parkinson's disease.

Authors:  Glenda E Gillies; Ilse S Pienaar; Shiv Vohra; Zahi Qamhawi
Journal:  Front Neuroendocrinol       Date:  2014-03-04       Impact factor: 8.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.